Adaptation and antibiotic tolerance of anaerobic Burkholderia pseudomallei

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 7, 2011, Pages 3313-3323

  Hamad, Mohamad A ^a   Austin, Chad R ^a   Stewart, Amanda L ^a   Higgins, Mike ^a   Vázquez Torres, Andrés ^a   Voskuil, Martin I ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; CHLORAMPHENICOL; COTRIMOXAZOLE; METRONIDAZOLE; TINIDAZOLE;

ABSCESS; ACIDITY; ANAEROBIC BACTERIUM; ANAEROBIC GROWTH; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL SURVIVAL; BACTERIAL VIABILITY; BACTERIUM CULTURE; BURKHOLDERIA PSEUDOMALLEI; DRUG TOLERANCE; GENE; GENE EXPRESSION PROFILING; MICROARRAY ANALYSIS; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; BURKHOLDERIA PSEUDOMALLEI; CEFTAZIDIME; HYDROGEN-ION CONCENTRATION; NITROIMIDAZOLES; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 79959230731     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00953-10     Document Type: Article

References (61)

1. Aardema, H., et al. 2005. Changing epidemiology of melioidosis? A case of acute pulmonary melioidosis with fatal outcome imported from Brazil. Epidemiol. Infect. 133:871-875.
2. Almirón, M., A. J. Link, D. Furlong, and R. Kolter. 1992. A novel DNA-binding protein with regulatory and protective roles in starved Escherichia coli. Genes Dev. 6:2646-2654. (Pubitemid 23052891)
3. Anderson, G. G., and G. A. O'Toole. 2008. Innate and induced resistance mechanisms of bacterial biofilms. Curr. Top. Microbiol. Immunol. 322:85-105.
4. Boulette, M. L., and S. M. Payne. 2007. Anaerobic regulation of Shigella flexneri virulence: ArcA regulates fur and iron acquisition genes. J. Bacteriol. 189:6957-6967.
5. Capestany, C. A., G. D. Tribble, K. Maeda, D. R. Demuth, and R. J. Lamont. 2008. Role of the Clp system in stress tolerance, biofilm formation, and intracellular invasion in Porphyromonas gingivalis. J. Bacteriol. 190:1436-1446.
6. Chaowagul, W. 2000. Recent advances in the treatment of severe melioidosis. Acta Trop. 74:133-137. (Pubitemid 30069784)
7. Cheng, A. C., and B. J. Currie. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18:383-416.
8. Currie, B. J., D. A. Fisher, N. M. Anstey, and S. P. Jacups. 2000. Melioidosis: acute and chronic disease, relapse and re-activation. Trans. R. Soc. Trop. Med. Hyg. 94:301-304.
9. Dance, D. A. 2000. Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts. Acta Trop. 74:159-168. (Pubitemid 30069788)
10. Dance, D. A., V. Wuthiekanun, W. Chaowagul, and N. J. White. 1989. The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. J. Antimicrob. Chemother. 24:295-309.
11. Ekaza, E., J. Teyssier, S. Ouahrani-Bettache, J. P. Liautard, and S. Köhler. 2001. Characterization of Brucella suis clpB and clpAB mutants and participation of the genes in stress responses. J. Bacteriol. 183:2677-2681. (Pubitemid 32249779)
12. Eschbach, M., et al. 2004. Long-term anaerobic survival of the opportunistic pathogen Pseudomonas aeruginosa via pyruvate fermentation. J. Bacteriol. 186:4596-4604. (Pubitemid 38891022)
13. Field, T. R., A. White, J. S. Elborn, and M. M. Tunney. 2005. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms. Eur. J. Clin. Microbiol. Infect. Dis. 24:677-687.
14. Fink, R. C., et al. 2007. FNR is a global regulator of virulence and anaerobic metabolism in Salmonella enterica serovar Typhimurium (ATCC 14028s). J. Bacteriol. 189:2262-2273. (Pubitemid 46411340)
15. Fuchs, S., J. Pané-Farré, C. Kohler, M. Hecker, and S. Engelmann. 2007. Anaerobic gene expression in Staphylococcus aureus. J. Bacteriol. 189:4275-4289. (Pubitemid 46847376)
16. 15N]nitrate in biological fluids. Anal. Biochem. 126:131-138.
17. Häußler, S., M. Rohde, and I. Steinmetz. 1999. Highly resistant Burkholderia pseudomallei small colony variants isolated in vitro and in experimental melioidosis. Med. Microbiol. Immunol. 188:91-97.
18. Holden, M. T. G., et al. 2004. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc. Natl. Acad. Sci. U. S. A. 101: 14240-14245.
19. Inglis, T. J. J., D. B. Rolim, and A. D. Q. Sousa. 2006. Melioidosis in the Americas. Am. J. Trop. Med. Hyg. 75:947-954.
20. Inoue, K., and K. Sugano. 2002. Metronidazol (MNZ). Nippon Rinsho 60(Suppl. 2):671-675. (In Japanese.)
21. Jenney, A. W., G. Lum, D. A. Fisher, and B. J. Currie. 2001. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int. J. Antimicrob. Agents 17: 109-113.
22. Jobin, M. P., F. Delmas, D. Garmyn, C. Diviès, and J. Guzzo. 1997. Molecular characterization of the gene encoding an 18-kilodalton small heat shock protein associated with the membrane of Leuconostoc oenos. Appl. Environ. Microbiol. 63:609-614.
23. Jones-Carson, J., et al. 2008. Inactivation of [Fe-S] metalloproteins mediates nitric oxide-dependent killing of Burkholderia mallei. PloS One 3:e1976.
24. Kvint, K., L. Nachin, A. Diez, and T. Nyström. 2003. The bacterial universal stress protein: function and regulation. Curr. Opin. Microbiol. 6:140-145.
25. Lewis, K. 2007. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5:48-56.
26. Liesack, W., S. Schnell, and N. P. Revsbech. 2000. Microbiology of flooded rice paddies. FEMS Microbiol. Rev. 24:625-645.
27. Loprasert, S., W. Whangsuk, R. Sallabhan, and S. Mongkolsuk. 2004. DpsA protects the human pathogen Burkholderia pseudomallei against organic hydroperoxide. Arch. Microbiol. 182:96-101.
28. Ludlum, D. B., R. J. Colinas, M. C. Kirk, and J. R. Mehta. 1988. Reaction of reduced metronidazole with guanosine to form an unstable adduct. Carcinogenesis 9:593-596.
29. Manes, G., and A. Balzano. 2004. Tinidazole: from protozoa to Helicobacter pylori - the past, present and future of a nitroimidazole with peculiarities. Expert Rev. Anti Infect. Ther. 2:695-705.
30. Mays, E. E., and E. A. Ricketts. 1975. Melioidosis: recrudescence associated with bronchogenic carcinoma twenty-six years following initial geographic exposure. Chest 68:261-263.
31. Mikamo, H., M. Ninomiya, and T. Tamaya. 2003. Anaerobic abscess. Nippon Rinsho 61(Suppl. 2):481-484. (In Japanese.)
32. Morrissey, I., and J. T. Smith. 1994. The importance of oxygen in the killing of bacteria by ofloxacin and ciprofloxacin. Microbios 79:43-53.
33. Müller, M. 1983. Mode of action of metronidazole on anaerobic bacteria and protozoa. Surgery 93:165-171. (Pubitemid 13093128)
34. Murray, P. R., E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.). 2003. Manual of clinical microbiology, 8th ed. ASM Press, Washington, DC.
35. Nachin, L., U. Nannmark, and T. Nyström. 2005. Differential roles of the universal stress proteins of Escherichia coli in oxidative stress resistance, adhesion, and motility. J. Bacteriol. 187:6265-6272. (Pubitemid 41318384)
36. Ngauy, V., Y. Lemeshev, L. Sadkowski, and G. Crawford. 2005. Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J. Clin. Microbiol. 43:970-972.
37. Park, M. K., R. A. Myers, and L. Marzella. 1992. Oxygen tensions and infections: modulation of microbial growth, activity of antimicrobial agents, and immunologic responses. Clin. Infect. Dis. 14:720-740.
38. Platt, M. D., et al. 2008. Proteomic, microarray, and signature-tagged mutagenesis analyses of anaerobic Pseudomonas aeruginosa at pH 6.5, likely representing chronic, late-stage cystic fibrosis airway conditions. J. Bacteriol. 190:2739-2758. (Pubitemid 351508174)
39. Reddy, G. B., P. A. Kumar, and M. S. Kumar. 2006. Chaperone-like activity and hydrophobicity of alpha-crystallin. IUBMB Life 58:632-641.
40. Rotz, L. D., A. S. Khan, S. R. Lillibridge, S. M. Ostroff, and J. M. Hughes. 2002. Public health assessment of potential biological terrorism agents. Emerg. Infect. Dis. 8:225-230.
41. Rubinstein, E., Z. Dreznik, and Z. Mark. 1982. Gentamicin and cefsulodin efficacy in a rat abscess model. Surg. Gynecol. Obstet. 155:363-368.
42. Schreiber, K., et al. 2006. Anaerobic survival of Pseudomonas aeruginosa by pyruvate fermentation requires an Usp-type stress protein. J. Bacteriol. 188: 659-668. (Pubitemid 43100553)
43. Sengupta, N., K. Paul, and R. Chowdhury. 2003. The global regulator ArcA modulates expression of virulence factors in Vibrio cholerae. Infect. Immun. 71:5583-5589.
44. 2 in abscesses, peritoneal fluid, and drainage fluid in the presence or absence of bacterial infection during and after abdominal surgery. Am. J. Surg. 166:24-27.
45. Singh, R., et al. 2008. PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science (New York, N.Y.) 322:1392-1395. (Pubitemid 352775253)
46. Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98:5116-5121.
47. Vander Wauven, C., A. Piérard, M. Kley-Raymann, and D. Haas. 1984. Pseudomonas aeruginosa mutants affected in anaerobic growth on arginine: evidence for a four-gene cluster encoding the arginine deiminase pathway. J. Bacteriol. 160:928-934.
48. Vorachit, M., P. Chongtrakool, S. Arkomsean, and S. Boonsong. 2000. Antimicrobial resistance in Burkholderia pseudomallei. Acta Trop. 74:139-144. (Pubitemid 30069785)
49. Voskuil, M. I. 2004. Mycobacterium tuberculosis gene expression during environmental conditions associated with latency. Tuberculosis (Edinb.) 84: 138-143. (Pubitemid 38857847)
50. Voskuil, M. I., et al. 2003. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198:705-713.
51. Wagner, C., R. Sauermann, and C. Joukhadar. 2006. Principles of antibiotic penetration into abscess fluid. Pharmacology 78:1-10. (Pubitemid 44387432)
52. Walters, M. C., F. Roe, A. Bugnicourt, M. J. Franklin, and P. S. Stewart. 2003. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to cipro- floxacin and tobramycin. Antimicrob. Agents Chemother. 47:317-323.
53. Wayne, L. G., and L. G. Hayes. 1996. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64:2062-2069.
54. White, N. J., et al. 1989. Halving of mortality of severe melioidosis by ceftazidime. Lancet ii:697-701. (Pubitemid 19243112)
55. Wiersinga, W. J., T. van der Poll, N. J. White, N. P. Day, and S. J. Peacock. 2006. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat. Rev. Microbiol. 4:272-282.
56. Wong, K. T., S. D. Puthucheary, and J. Vadivelu. 1995. The histopathology of human melioidosis. Histopathology 26:51-55.
57. Wuthiekanun, V., et al. 2005. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J. Antimicrob. Chemother. 55:1029-1031.
58. Wuthiekanun, V., and S. J. Peacock. 2006. Management of melioidosis. Expert Rev. Anti Infect. Ther. 4:445-455.
59. Yabuuchi, E., et al. 1992. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol. Immunol. 36:1251-1275.
60. Yoon, S. S., et al. 2002. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 3:593-603. (Pubitemid 35252267)
61. Zúñiga, M., G. Pérez, and F. González- Candelas. 2002. Evolution of arginine deiminase (ADI) pathway genes. Mol. Phylogenet. Evol. 25:429-444.